Mixed glioma
Clinical trials for Mixed glioma explained in plain language.
Never miss a new study
Get alerted when new Mixed glioma trials appear
Sign up with your email to follow new studies for Mixed glioma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI-Designed vaccine takes on deadly brain cancer in first human trial
Disease control Recruiting nowThis early-phase trial tests a personalized vaccine called Tamavaq NeoVaccine in 29 adults with newly diagnosed glioma, a type of brain cancer. The vaccine is custom-made for each patient using AI and quantum mechanics to target unique cancer markers. The main goal is to check if…
Matched conditions: MIXED GLIOMA
Early phase 1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can this drug cross the Brain's barrier to fight tumors?
Knowledge-focused Recruiting nowThis early-stage trial is testing whether the drug ulixertinib can cross the blood-brain barrier in people with recurrent brain tumors called gliomas. About 40 adults will take the drug before surgery to see how much reaches the tumor and how safe it is. The goal is to learn if t…
Matched conditions: MIXED GLIOMA
Early phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC